Format

Send to

Choose Destination
Clin Transl Med. 2016 Mar;5(1):16. doi: 10.1186/s40169-016-0095-4. Epub 2016 Apr 29.

Mitochondrial transplantation for therapeutic use.

Author information

1
Division of Cardiac Surgery, Boston Children's Hospital, 300 Longwood Ave., Enders Building, EN 407, Boston, MA, 02115, USA. james_mccully@hms.harvard.edu.
2
Harvard Medical School, Boston, MA, USA. james_mccully@hms.harvard.edu.
3
Division of Cardiac Surgery, Beth Israel Deaconess Medical Center, 110 Francis Street, Suite 2A, Boston, MA, 02115, USA.
4
Harvard Medical School, Boston, MA, USA.
5
Division of Cardiac Surgery, Boston Children's Hospital, 300 Longwood Ave., Enders Building, EN 407, Boston, MA, 02115, USA.
6
Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, 300 Longwood Ave., Endres Building, EN 312, Boston, MA, 02115, USA.

Abstract

Mitochondria play a key role in the homeostasis of the vast majority of the body's cells. In the myocardium where mitochondria constitute 30 % of the total myocardial cell volume, temporary attenuation or obstruction of blood flow and as a result oxygen delivery to myocardial cells (ischemia) severely alters mitochondrial structure and function. These alterations in mitochondrial structure and function occur during ischemia and continue after blood flow and oxygen delivery to the myocardium is restored, and significantly decrease myocardial contractile function and myocardial cell survival. We hypothesized that the augmentation or replacement of mitochondria damaged by ischemia would provide a mechanism to enhance cellular function and cellular rescue following the restoration of blood flow. To test this hypothesis we have used a model of myocardial ischemia and reperfusion. Our studies demonstrate that the transplantation of autologous mitochondria, isolated from the patient's own body, and then directly injected into the myocardial during early reperfusion augment the function of native mitochondria damaged during ischemia and enhances myocardial post-ischemic functional recovery and cellular viability. The transplanted mitochondria act both extracellularly and intracellularly. Extracellularly, the transplanted mitochondria enhance high energy synthesis and cellular adenosine triphosphate stores and alter the myocardial proteome. Once internalized the transplanted mitochondria rescue cellular function and replace damaged mitochondrial DNA. There is no immune or auto-immune reaction and there is no pro-arrhythmia as a result of the transplanted mitochondria. Our studies and those of others demonstrate that mitochondrial transplantation can be effective in a number of cell types and diseases. These include cardiac and skeletal muscle, pulmonary and hepatic tissue and cells and in neuronal tissue. In this review we discuss the mechanisms leading to mitochondrial dysfunction and the effects on cellular function. We provide a methodology for the isolation of mitochondria to allow for clinical relevance and we discuss the methods we and others have used for the uptake and internalization of mitochondria. We foresee that mitochondrial transplantation will be a valued treatment in the armamentarium of all clinicians and surgeons for the treatment of varied ischemic disorders, mitochondrial diseases and related disorders.

KEYWORDS:

Ischemia/reperfusion injury; Mitochondria; Myocardium; Surgery

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center